
Reducing mortality with cotrimoxazole preventive therapy at initiation of antiretroviral therapy in South Africa
Author(s) -
Christopher J. Hoffmann,
Katherine Fielding,
Salome Charalambous,
Craig Innes,
Richard E. Chaisson,
Alison D. Grant,
Gavin Churchyard
Publication year - 2010
Publication title -
aids
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.195
H-Index - 216
eISSN - 1473-5571
pISSN - 0269-9370
DOI - 10.1097/qad.0b013e32833ac6bc
Subject(s) - medicine , cart , hazard ratio , cohort , proportional hazards model , cohort study , antiretroviral therapy , confounding , immunology , confidence interval , surgery , viral load , human immunodeficiency virus (hiv) , mechanical engineering , engineering
To assess the effectiveness of cotrimoxazole preventive therapy (CPT) among individuals with CD4 cell count above 200 cells/microl and varying WHO clinical stages in reducing mortality during combination antiretroviral therapy (cART).